| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/24/2008 | CN101327295A Chinese medicine for releasing toxicity and relieving inflammation |
| 12/24/2008 | CN101327294A Chinese medicinal composition for treating common cold, acute and chronic tracheitis and preparation method thereof |
| 12/24/2008 | CN101327282A Use of Carex rigescens in preparing antivirus medicament |
| 12/24/2008 | CN101327278A Sang Ju heat-cleaning fire toxin-releasing king tea composition |
| 12/24/2008 | CN101327277A Heat-cleaning fire toxin-releasing king tea composition |
| 12/24/2008 | CN101327272A Rejuvenation ball for treating pulmonary tuberculosis and preparation method |
| 12/24/2008 | CN101327271A Pharmaceutical composition for treating herpes and method of using the same |
| 12/24/2008 | CN101327270A Chinese medicine for treating fish bone-pricking wound induced infection contamination |
| 12/24/2008 | CN101327267A Compound Houttuynia cordata injection for animals and preparation method thereof |
| 12/24/2008 | CN101327266A Oral cavity nursing agent for preventing and treating oral disease induced by Helicobacter pylori infection contamination |
| 12/24/2008 | CN101327262A Qingkailing suppositorium |
| 12/24/2008 | CN101327260A Qingji capsules |
| 12/24/2008 | CN101327249A Use of Radix salvia miltiorrhiza extract for treating septicemia |
| 12/24/2008 | CN101327242A Prepared honeysuckle, processing method thereof, and its uses in preparing drink or medicament for clearing heat and cooling blood, activating blood and resolving stasis |
| 12/24/2008 | CN101327238A Medicament composition for eye |
| 12/24/2008 | CN101327236A Use of pseudo-ginseng saponin component for treating septicemia |
| 12/24/2008 | CN101327235A Use of pseudo-ginseng saponins for treating septicemia |
| 12/24/2008 | CN101327233A Compound external-use formulation for treating gonorrhoea and nongonococcal urethritis |
| 12/24/2008 | CN101327220A Use of pseudo-ginseng saponin R1 in preparing medicament for treating liver damage |
| 12/24/2008 | CN101327209A Dihydromyricetin injection, powder injection and preparation method thereof |
| 12/24/2008 | CN101327201A Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 12/24/2008 | CN101327192A Fleraxacin for injection and preparation method thereof |
| 12/24/2008 | CN101327191A Lactobionic acid azithromycin for injections and preparation method thereof |
| 12/24/2008 | CN101327010A Method for preparing amber ginseng |
| 12/24/2008 | CN101326948A Chewing gum containing Zedoary turmeric oil component and preparation thereof |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CN100445288C Bilobalide B derivatives and pharmaceutical application thereof |
| 12/24/2008 | CN100445277C Cesong alkyl type diterpine, its preparation method and use |
| 12/24/2008 | CN100445271C Amide derivative |
| 12/24/2008 | CN100444875C Common cold heat clearing chewing tablet and its preparation method |
| 12/24/2008 | CN100444866C Synergistic medicinal composition |
| 12/24/2008 | CN100444865C Synergistic medicinal composition containing dicyclic alcohol |
| 12/24/2008 | CN100444863C Chinese medicine composition for diminishing-inflammation and detoxication and its preparing method and use |
| 12/24/2008 | CN100444853C Transaminase lowering dripping pill and its prepn |
| 12/24/2008 | CN100444852C Compound Chinese medicine material for sterilizing AIDS virus and influenza virus, production thereof |
| 12/24/2008 | CN100444848C Pharmaceutical composition for improved administration of HIV gp41-derived peptides,And its use in therapy |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444834C Effervescence tablet for treating wind-cold type cold and preparation process thereof |
| 12/24/2008 | CN100444833C Oral dosage form for controlled drug release |
| 12/24/2008 | CA2855098A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | CA2726420A1 Topical dental solution of chlorhexidine in sumatra benzoin bp/ep and methods of manufacturing and evaluating same for compliance with international regulatory specifications |
| 12/24/2008 | CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof |
| 12/24/2008 | CA2692028A1 Azapeptide derivatives |
| 12/24/2008 | CA2691223A1 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and aids |
| 12/24/2008 | CA2691091A1 Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 12/24/2008 | CA2691033A1 Capsid proteins and uses therefore |
| 12/24/2008 | CA2691019A1 Indazolamide derivatives |
| 12/24/2008 | CA2690668A1 Vaccines containing canine parvovirus genetic variants |
| 12/24/2008 | CA2690271A1 Chlamydia antigens |
| 12/24/2008 | CA2689524A1 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x |
| 12/24/2008 | CA2689181A1 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
| 12/24/2008 | CA2687217A1 Antibiotic compounds |
| 12/23/2008 | US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| 12/23/2008 | US7468435 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 12/23/2008 | US7468420 Process for purifying glycopeptide phosphonate derivatives |
| 12/23/2008 | US7468388 Using 5-aceylamino-4-azido-4-nitrophenoxycarbonyloyl) -(2-oxo (1,3-dioxolan-4-yl)-5,6-dihydropyran-2-carxylic acid methyl ester; therapy for myxovirus infections; active materials; stability; long time in lungs |
| 12/23/2008 | US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 12/23/2008 | US7468364 High oral absorption; gramnegative, grampositive bacteria and antibiotic resistant Staphlococcus pneumonia, Hemophilus influenza |
| 12/23/2008 | US7468357 Nucleosides with anti-hepatitis B virus activity |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468259 Influenza vaccine |
| 12/23/2008 | US7468194 Administering liposomes containing povidone iodine for therapy of bacterial infection |
| 12/23/2008 | US7468190 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages |
| 12/23/2008 | US7468181 Means and methods for the production of adenovirus vectors |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | CA2596497C Nucleotide analog compositions |
| 12/23/2008 | CA2596320C Nucleotide analog compositions |
| 12/23/2008 | CA2448058C Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 12/23/2008 | CA2419067C Injectable composition comprising benzimidazole compound and strong alkali |
| 12/23/2008 | CA2379003C Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides |
| 12/23/2008 | CA2307040C Multilayer conductive appliance having wound healing and analgesic properties |
| 12/23/2008 | CA2263584C Orally applicable formulation of quinolone or naphthyridone carboxylic acids |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/23/2008 | CA2175966C Antibacterial oral gel composition for application to dental implant areas |
| 12/23/2008 | CA2139515C Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 12/18/2008 | WO2008154601A1 Anti-viral inhibitors and methods of use |
| 12/18/2008 | WO2008154246A1 Hiv integrase inhibitors |
| 12/18/2008 | WO2008154008A1 Methods and compositions for inhibiting toll-like receptor mediated immune responses |
| 12/18/2008 | WO2008153655A2 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis |
| 12/18/2008 | WO2008153077A1 Anti-norovirus agent, and composition comprising the same |
| 12/18/2008 | WO2008152603A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 12/18/2008 | WO2008152447A2 Staphylococcus aureus specific anti-infectives |
| 12/18/2008 | WO2008152387A1 Quinazoline derivatives as pi3 kinase inhibitors |
| 12/18/2008 | WO2008152265A1 Use of isoosmotic seawater-based ionic solutions for manufacturing medical devices for the prevention of complications of the common cold or of the flu syndrome |
| 12/18/2008 | WO2008152127A1 Terpenes with antifungal activity against malassezia yeasts |
| 12/18/2008 | WO2008151502A1 Enrofloxacin microcapsule formulation and preparation method thereof |
| 12/18/2008 | WO2008151434A1 Small cationic antimicrobial peptides |
| 12/18/2008 | WO2008151412A1 Synergistic inhibition of h1n1 and h3n2 influenza viruses by aurintricarboxylic acid with amantadine |
| 12/18/2008 | WO2008130879A3 Tetrahydroindole and tetrahydroindazole derivatives |
| 12/18/2008 | WO2008128654A3 Use of fungicides for treating fish mycoses |
| 12/18/2008 | WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists |
| 12/18/2008 | WO2008099068B1 Liquid anhydrous composition to be incorporated into the drinking water of cattle |
| 12/18/2008 | WO2008079339A3 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| 12/18/2008 | WO2008036139A3 Inhibitors of mshc and homologs thereof, and methods of identifying same |
| 12/18/2008 | WO2003024455A8 Stent coated with a sustained-release drug delivery and method for use thereof |
| 12/18/2008 | US20080312449 New Compounds |
| 12/18/2008 | US20080312417 Ucp5 |
| 12/18/2008 | US20080312412 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines |
| 12/18/2008 | US20080312407 Glycopeptide phosphonate derivatives |
| 12/18/2008 | US20080312327 Organic Compositions |